The influence of pressure-con trolled postischemic reperfusion (Rp) on functional and metabolic parame ters in hearts of sham-operated rats and hypertrophied hearts of rats with aortic constriction were studied. Hy pertrophied hearts are considered to be more susceptible to ischemia.
The hearts were perfused in the Langendorff-technique for thirty minutes at 35°C with Krebs-Hense leit bicarbonate buffer at a perfusion pressure (PP) of 75 mmHg and for five minutes at 15°C with St. Thomas' Hospital cardioplegic solu tion at a PP of 60 mmHg. After a per iod of global ischemia of forty min utes' duration at 15 ° C, reperfusion was started either abruptly (aRp: PP 75 mmHg immediately) or gently (gRp: PP 75 mmHg within thirty minutes); it lasted for forty-five min utes. Intraventricular peak systolic pressure (ISP) was monitored and en ergy-rich compounds (ATP, ADP, AMP, CrP, free Cr) were analyzed.
In normal hearts, metabolic re covery was not affected by the mode of reperfusion, but functional recov ery (ISP) averaged 88% of the preis chemic control value after gRp as compared with 73% after aRp.
In hypertrophied hearts, gentle reperfusion ameliorated both meta bolic and functional recovery. At forty-five minute recovery, CrP aver aged 5.1 μmol/g ww after aRp and 6.6 μmol/g ww after gRp (p < 0.01), and ISP amounted to 73% of the pre ischemic control after aRp and to 85% after gRp.
Get full access to this article
View all access options for this article.
References
1.
Bulkley BH, Hutchins GM: Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization. Circulation56:906-913, 1977.
2.
Follette DM, Fey K., Buckberg GD, et al: Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg82:221-238, 1981.
3.
Pasque MK, Spray TL, Pellom GL, et al: Ribose-enhanced myocardial recovery following ischemia in the isolated working rat heart. J Thorac Cardiovasc Surg83:390-398, 1982.
4.
Bixler TJ, Gardner TJ, Flaherty JT, et al: Beneficial effects of alkalotic reperfusion following ischemic cardiac arrest. J Surg Res24:488-494, 1978.
5.
Krieger Wjg, ter Welle HF, Fiolet Jwt, et al: Tissue osmolality, metabolic response, and reperfusion in myocardial ischemia. Basic Res Cardiol79:562-571, 1984.
6.
Humphrey SM, Seelye RN: Improved functional recovery of ischemic myocardium by suppression of adenosine catabolism. J Thorac Cardiovasc Surg84:16-22, 1982.
7.
Lazar HL, Buckberg GD, Manganaro AJ, et al: Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg79:350-359, 1980.
8.
Peyton RB, Van Trigt P, Pellom GL, et al: Improved tolerance to ischemia in hypertrophied myocardium by preischemic enhancement of adenosine triphosphate. J Thorac Cardiovasc Surg84:11-15, 1982.
9.
Isselhard W. , Eitenmüller J., Mäurer W., et al: Increase in myocardial adenine nucleotides induced by adenosine: Dosage, mode of application and duration, species differences . J Mol Cell Cardiol12:619-634, 1980.
Shlafer M., Kane PF, Kirsh MM: Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg83:830-839, 1982.
12.
Swanson DK, Myerowitz PD: Effect of reperfusion temperature and pressure on the functional and metabolic recovery of preserved hearts. J Thorac Cardiovasc Surg86:242-251, 1983.
13.
Engelmann RM , Adler S., Gouge TH, et al: The effect of normothermic anoxic arrest and ventricular fibrillation on the coronary blood flow distribution of the pig. J Thorac Cardiovasc Surg69:858-869, 1975.
14.
Lewitsky S. : Myocardial protection of the hypertrophied heart. Ann Thorac Surg41:2-3, 1986.
15.
Sink JD, Pellom GL, Currie WD, et al: Response to hypertrophied myocardium to ischemia. Correlation with biomechanical and physiological parameters. J Thorac Cardiovasc Surg81:865-872, 1981.
16.
Morkin E., Ashford TP: Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol215:1409-1413, 1968 .
17.
Döring HJ, Dehnert H.: Das isolierte perfundierte Warmbluter-Herz nach Langendorff. Biomesstechnik-Verl, 1. Aufl. 1985 .
18.
Neely JR, Liebermeister H., Battersby EJ, et al: Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol212:804-814, 1967.
19.
Braimbridge MV, Chayen J., Bitensky L., et al: Cold cardioplegia or continuous coronary perfusion?J Thorac Cardiovasc Surg74:900-906, 1977.
20.
Robinson LA , Braimbridge MV, Hearse DJ: Particulate contamination: A potential hazard of cardioplegia. Lancet1:995-996, 1983.
21.
Wollenberger A., Ristau O., Schoffa G.: Eine einfache Technik der extrem schnellen Abkühlung größerer Gewebstücke. Pflügers Arch270:399-412, 1960.
Isselhard W. , Merguet H.: Metabolite des Glykolyse-Cyclus und des Adenylsäure-Phosphokreatin-Systems in schlagenden und urchbluteten Warmblüterherzen unter vershiedenen Versuchsbedingungen . Pflügers Arch276:211-235, 1962.
24.
Isselhard W. , Merguet H., Palm K.: Bestimmung des Gesamtglykogens neben säurelöslichen Metaboliten in Perchlorsäure-Organhomogenaten. Z ges. exp Med136:174-182, 1962.
25.
Lamprecht W. , Trautschold I.: Adenosin-5'-triphosphat: Bestimmung mit Hexokinase und Glucose-6-phosphate-Dehydrogenase . In: Methoden der enzymatischen Analyse, ed. by Bergmeyer HU, Bd II, 3. Aufl., 1974, pp 2151-2160.
26.
Atkinson DE : The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry7:4030-4034, 1968.
27.
Iyengar Srk , Ramchand S., Charette Ejp, et al: Anoxic cardiac arrest: An experimental and clinical study of its effects. J Thorac Cardiovasc Surg66:722-731, 1973.
28.
Hottenrott CE, Towers B., Kurkji HJ, et al: The hazard of ventricular fibrillation in hypertrophied ventricles during cardiopulmonary bypass. J Thorac Cardiovasc Surg66:742-753, 1973.
29.
Reis RL, Cohn LH, Morrow AG: Effects of induced ventricular fibrillation on ventricular performance and cardiac metabolism. Circulation36 (Suppl I):234-243, 1967.
30.
Mavroudis C. , Ebert PA: Effects of high potassium cardioplegia and hypothermia on myocardial compliance and distribution of water and potassium. II. The hypertrophied canine heart. Surgery85:662-670, 1979.
31.
Goss RJ: Hypertrophy versus hyperplasia. Science153:1615-1620, 1966.
32.
Sink JD, Pellom GL, Currie WD, et al: Protection of mitochondrial function during ischemia by potassium cardioplegia: Correlation with ischemic contracture. Circulation60 (Suppl 1):158-163, 1979.
33.
Jones RN, Currie WD, Olsen CO, et al: Recovery of metabolic function in hypertrophied canine hearts following global ischemia. Circulation62 (Suppl 3):80, 1980.
34.
Sink JD, Pellom GL, Currie WD, et al: Relationship between ischemic contracture and mitochondrial function. Surg Forum29:298-299, 1978.
35.
Hearse DJ, Stewart DA, Chain EB: Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart . Circ Res35:448-457, 1978.
36.
Isselhard W. : Biochemistry: Index of the functional state of the heart?Br J Anaesth60:23-27, 1988.
